is glp 1 r the same as retatrutide vs Tirzepatide: Key Differences Explained (2026) Retatrutide Obesity Treatment Shows Promising

GLP-1 agonists such as Ozempic should generally be avoided in individuals with: A personal or family history of medullary thyroid carcinoma Multiple Endocrine Neoplasia syndrome type 2 (MEN2) A prior history of pancreatitis Progressive diabetic retinopathy, particularly in those with long-standing or poorly controlled diabetes Congestive heart failure, where fluid balance, heart rate, and medication interactions require close monitoring (35) A thorough medical history and medication review are essential before initiating therapy to determine whether GLP-1 agonists are appropriate or contraindicated

Dual Activation: The system directly supports the GLP-1 pathway within L-cells and indirectly activates GLP-1 by optimizing the gut microbiome

This is why its key to have an IDT approach

We also probably see extreme examples of excessive exercise